US Stock MarketDetailed Quotes
GELS Gelteq
- 1.810
- -0.020-1.09%
Close Nov 25 16:00 ET
- 1.810
- 0.0000.00%
Post 20:01 ET
17.08MMarket Cap-7387P/E (TTM)
1.970High1.710Low34.89KVolume1.850Open1.830Pre Close64.22KTurnover1.14%Turnover RatioLossP/E (Static)9.44MShares4.01052wk High1.74P/B5.52MFloat Cap1.42052wk Low--Dividend TTM3.05MShs Float4.010Historical High--Div YieldTTM14.21%Amplitude1.420Historical Low1.840Avg Price1Lot Size
About Gelteq Company
Gelteq Ltd. is a biotechnology company. It focuses on the development and commercialization of white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. The firm also offers edible gels. The company was founded by Nathan J. Givoni and Simon H. Szewach on October 15, 2018 and is headquartered in Melbourne, Australia.
Company Profile
SymbolGELS
Company NameGelteq
Listing DateOct 29, 2024
Issue Price4.00
Founded2017
CEOMr. Nathan J. Givoni
MarketNASDAQ
Fiscal Year Ends06-30
Address639-641 Glenhuntly Road,Caulfield
CityMelbourne
ProvinceVictoria (VIC)
CountryAustralia
Zip Code3162
Phone61-3-9087-3990
Websitehttp://www.gelteq.com
Company Executives
- Name
- Position
- Salary
- Nathan J. Givoni
- Director and Chief Executive Officer
- --
- Anthony W. Panther
- Chief Financial Officer and Principal Accounting Officer
- --
- Simon H. Szewach
- Executive Chairman of the Board
- --
- The Honourable Philip A. Dalidakis
- Independent Director
- --
- Professor David Morton
- Independent Director
- --
- Jeffrey W. Olyniec
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
